生展

-0.10 (-0.13%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

78.707成交張數9.44本益比0.91股價淨值比6.35%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	32	23	25.9%	1.90	86.39	9.8%	7.2%	-0.8	-1.0
2026Q1	31	23	25.8%	1.84	83.81	11.0%	8.0%	1.2	1.2
2025Q4	30	24	22.1%	2.20	87.57	11.8%	8.9%	0.7	0.7
2025Q3	31	23	24.0%	2.06	86.13	12.9%	9.6%	1.8	1.8
2025Q2	31	22	28.1%	1.75	82.97	12.8%	8.9%	0.0	-0.0
2025Q1	31	22	29.5%	1.63	79.77	11.5%	7.8%	0.6	0.5
2024Q4	31	22	27.5%	2.22	82.51	11.0%	7.8%	1.4	1.4
2024Q3	30	22	27.3%	2.21	80.54	11.2%	7.9%	1.7	1.6
2024Q2	32	21	33.3%	1.72	77.84	11.5%	7.6%	-0.1	-0.2
2024Q1	32	21	35.1%	1.65	75.87	13.1%	8.4%	0.4	0.3
2023Q4	31	21	31.4%	1.94	78.65	13.3%	8.9%	1.4	1.1
2023Q3	30	21	32.0%	1.57	76.53	14.3%	9.4%	2.0	1.9
2023Q2	31	20	35.1%	1.44	73.93	16.1%	10.0%	-0.3	-0.4
2023Q1	31	19	36.8%	1.40	71.18	17.9%	11.9%	1.0	1.0
2022Q4	31	20	35.1%	1.55	73.49	17.1%	11.7%	0.8	0.7
2022Q3	31	19	37.5%	1.43	70.88	17.6%	11.8%	2.1	-3.2
2022Q2	31	18	40.6%	1.13	67.51	17.1%	11.0%	-0.4	-0.5
2022Q1	25	17	29.9%	2.12	63.98	15.8%	11.0%	0.3	0.2
2021Q4	24	18	26.7%	2.43	65.36	14.0%	10.5%	1.3	1.1
2021Q3	23	17	26.4%	2.39	62.89	12.9%	9.5%	1.6	1.5
2021Q2	23	16	29.8%	2.03	60.36	12.9%	9.3%	-0.2	-0.5
2021Q1	23	16	31.0%	1.93	57.99	14.3%	10.2%	0.6	0.6
2020Q4	21	16	23.5%	3.26	60.00	13.8%	10.6%	1.6	1.3
2020Q3	21	16	26.1%	2.79	58.46	16.2%	11.3%	0.5	-1.1
2020Q2	21	15	25.9%	2.82	56.26	17.3%	11.8%	0.1	-0.4
2020Q1	20	15	26.0%	2.90	53.51	16.6%	11.3%	0.0	-0.3
2019Q4	19	15	22.7%	3.67	55.03	16.0%	11.7%	0.8	0.5
2019Q3	18	12	35.1%	2.45	51.62	17.9%	11.6%	0.8	0.6
2019Q2	15	9	40.1%	1.89	39.31	21.8%	13.5%	-0.2	-0.3
2019Q1	15	9	39.0%	2.04	39.27	18.2%	11.7%	1.1	1.1
2018Q4	13	9	32.9%	1.91	37.80	16.4%	10.9%	0.4	0.3
2018Q3	13	8	36.0%	1.72	35.94	14.8%	9.6%	0.4	0.2
2018Q2	12	8	35.4%	1.73	37.25	17.3%	11.1%	-0.6	-0.6
2018Q1	11	8	31.1%	2.10	36.93	20.0%	13.5%	0.5	0.2
2017Q4	12	8	34.4%	1.80	36.38	21.2%	13.4%	0.5	0.6
2017Q3	11	7	34.1%	1.93	35.20	–	–	0.5	0.4
2017Q2	11	7	36.0%	1.92	32.44	–	–	0.5	0.5
2017Q1	10	7	34.2%	2.10	31.32	–	–	0.1	-1.8